Senior insider sale
Senior Vice President, R&D at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.82M
72.45K shares
What this filing means
ROTE WILLIAM E. plans to sell 72.45K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.82M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001959173-26-000560
Officer· Senior Vice President, R&D
Since Nov 2018
72.45K
Shares to sell
$2.82M
Approx. market value
12.45K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/2/2026
12.45KTotal acquired12.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/2/2026 | Restricted Stock Vesting Compensation | 12.45K | — |
| Total | 12.45K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
60K
Market value
$2.41M
12/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.45K
Market value
$409.1K
2/3/2026
Total
Units
72.45K
Value
$2.82M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/24/2025 | 60K | $2.41M | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 12.45K | $409.1K | NASDAQ | Planned |
| Total | 72.45K | $2.82M | ||